Affinage

CTNNBL1

Beta-catenin-like protein 1 · UniProt Q8WYA6

Length
563 aa
Mass
65.2 kDa
Annotated
2026-06-09
100 papers in source corpus 6 papers cited in narrative 6 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 4/4 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CTNNBL1 is a nuclear armadillo (ARM) domain-containing protein that operates as a selective NLS-binding adaptor coupling nuclear import recognition to spliceosome integrity (PMID:21385873, PMID:26130721). Distinct from karyopherin-α family transport receptors, its ARM domain binds the nuclear localization sequences of the CDC5L and Prp31 components of the Prp19 spliceosomal complex, and it stabilizes complex architecture by facilitating CWC15–CDC5L association; loss of CTNNBL1 lowers steady-state Prp19 complex levels and delays cell division (PMID:21385873, PMID:26130721). Through its associated splicing activity it governs alternative splicing of specific transcripts and supports cell proliferation and invasion (PMID:28501461). Separately, CTNNBL1 binds the conformational NLS of the antibody-diversifying enzyme AID, partially promoting AID nuclear accumulation and enabling efficient immunoglobulin hypermutation and IgV gene diversification, while being dispensable for class switch recombination (PMID:18722174, PMID:21385873, PMID:20585033).

Mechanistic history

Synthesis pass · year-by-year structured walk · 6 steps
  1. 2003 Medium

    Initial characterization established CTNNBL1 as a nuclear ARM-motif protein and mapped an apoptosis-inducing activity to its C-terminus, providing the first functional foothold for an otherwise uncharacterized gene.

    Evidence cDNA cloning and transfection of full-length and truncation constructs in CHO cells with imaging and cell-death quantification

    PMID:12659813

    Open questions at the time
    • Overexpression apoptosis phenotype not linked to a physiological pathway
    • No endogenous binding partners identified
    • ARM domain function undefined at this stage
  2. 2008 High

    Identifying CTNNBL1 as a physical partner of AID and of the Prp19 spliceosomal complex connected the protein simultaneously to antibody diversification and to RNA splicing machinery.

    Evidence Yeast two-hybrid, reciprocal co-immunoprecipitation, and targeted gene inactivation in DT40 B cells with hypermutation/CSR/IgV diversification assays

    PMID:18722174

    Open questions at the time
    • Mechanism by which CTNNBL1 promotes AID activity not resolved
    • Whether the splicing and AID functions are mechanistically linked unclear
  3. 2010 Medium

    A clean CTNNBL1-null B-cell knockout showed normal class switch recombination, separating CTNNBL1's contribution from a general requirement for CSR and refining which AID functions depend on it.

    Evidence Gene targeting to generate CTNNBL1-null CH12F3 cells with CSR assay

    PMID:20585033

    Open questions at the time
    • Does not explain the CSR defect of AID mutants that fail to bind CTNNBL1
    • Hypermutation phenotype in this system not addressed
  4. 2011 High

    Defining CTNNBL1 as an NLS-binding protein distinct from karyopherins explained both its AID and spliceosome associations as recognition of nuclear localization sequences via its ARM domain.

    Evidence Co-immunoprecipitation, direct binding assays, NLS-residue mutagenesis, and localization in CTNNBL1-deficient cells

    PMID:21385873

    Open questions at the time
    • AID nuclear accumulation defect only partial, implying redundant import routes
    • Functional consequence of Prp31 NLS binding not established
  5. 2015 High

    Mapping CTNNBL1 as a chaperone that promotes CWC15–CDC5L assembly established a concrete mechanism for how it maintains Prp19 complex integrity and supports timely cell division.

    Evidence Crosslinking and hydrogen-deuterium exchange mass spectrometry, in vitro association assays, and in vivo CTNNBL1 deficiency with complex quantification and cell division assays

    PMID:26130721

    Open questions at the time
    • Structural basis of the CTNNBL1/CWC15 exchange on CDC5L not solved at atomic resolution
    • Direct link between this chaperone role and splicing catalysis not shown
  6. 2017 Medium

    Linking CTNNBL1 to control of specific alternative splicing events and to proliferation/invasion phenotypes connected its spliceosomal role to a cancer-relevant cellular output.

    Evidence siRNA knockdown in ovarian cancer cell lines with proliferation/invasion assays and RNA-seq splicing analysis (IFI16, FOXM1)

    PMID:28501461

    Open questions at the time
    • Whether splicing changes are direct CTNNBL1 targets vs secondary to Prp19 destabilization unclear
    • Causal contribution of individual splicing events to the proliferation phenotype not dissected

Open questions

Synthesis pass · forward-looking unresolved questions
  • How CTNNBL1's NLS-recognition activity is integrated with karyopherin-dependent import and whether its spliceosomal chaperone role mechanistically underlies its support of AID-driven hypermutation remain unresolved.
  • No structural model of CTNNBL1 bound to a conformational NLS
  • Unknown whether AID and spliceosome functions share a common biochemical basis
  • Physiological in vivo role beyond cell-line systems undefined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 2 GO:0044183 protein folding chaperone 1
Localization
GO:0005634 nucleus 2
Pathway
R-HSA-8953854 Metabolism of RNA 2 R-HSA-168256 Immune System 1
Complex memberships
Prp19 complex

Evidence

Reading pass · 6 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2008 CTNNBL1 physically interacts with AID (activation-induced deaminase) as identified by yeast two-hybrid and co-immunoprecipitation assays. AID mutants that disrupt CTNNBL1 interaction show severely diminished somatic hypermutation and class switch recombination. Targeted inactivation of CTNNBL1 in DT40 B cells also considerably diminishes IgV diversification. CTNNBL1 associates with the Prp19 complex of the spliceosome via its CDC5L component. Yeast two-hybrid, co-immunoprecipitation, targeted gene inactivation in DT40 cells, functional hypermutation/CSR assays Molecular cell High 18722174
2011 CTNNBL1 is a novel NLS (nuclear localization sequence)-binding protein distinct from karyopherin-α family members. It binds the NLS of the CDC5L component of the Prp19 complex and also interacts with the NLS of splicing factor Prp31. NLS binding is mediated by the CTNNBL1 armadillo (ARM) domain. The CTNNBL1/AID interaction depends on amino acids forming the AID conformational NLS, and CTNNBL1-deficient cells show a partial defect in AID nuclear accumulation. The CTNNBL1 N-terminal region itself binds karyopherin-α (rather than karyopherin-β), suggesting a role divergent from canonical nuclear transport. Co-immunoprecipitation, direct binding assays, mutational analysis of NLS residues, cellular localization studies in CTNNBL1-deficient cells The Journal of biological chemistry High 21385873
2010 CTNNBL1 is dispensable for Ig class switch recombination (CSR) in mouse CH12F3 cells; disruption of both CTNNBL1 alleles by gene targeting yielded normal CSR levels, indicating the CSR defect of AID mutants that fail to bind CTNNBL1 is not due to loss of CTNNBL1-dependent CSR function per se. Gene targeting (homologous recombination) to generate CTNNBL1-null CH12F3 cells, CSR assay Journal of immunology Medium 20585033
2015 CTNNBL1 facilitates the association of CWC15 with CDC5L within the Prp19 spliceosomal complex, acting as a chaperone for complex integrity. In vitro, CTNNBL1 enhances CWC15–CDC5L association; there is an overlapping binding region on CDC5L for CTNNBL1 and CWC15, suggesting they can exchange places. In vivo, CTNNBL1 deficiency reduces steady-state levels of the Prp19 complex and impairs CWC15–CDC5L interaction, leading to delayed initiation of cell division. Amine crosslinking and hydrogen-deuterium exchange coupled to mass spectrometry, in vitro association assays, in vivo CTNNBL1 knockdown/deficiency with Prp19 complex quantification and cell division assay Nucleic acids research High 26130721
2003 CTNNBL1 encodes a 563-amino-acid armadillo (ARM) motif-containing nuclear protein. Transient overexpression in CHO cells localizes to the nucleus and induces apoptosis; a carboxy-terminal fragment induces apoptosis at a higher rate than full-length, mapping apoptosis-inducing activity to the C-terminal region. The gene contains a minor-class AT–AC intron (intron 4). cDNA cloning, transfection of CHO cells with full-length and truncation constructs, subcellular localization by imaging, cell death quantification Genomics Medium 12659813
2017 CTNNBL1 is upregulated in high-grade serous ovarian carcinoma and promotes proliferation and invasion of ovarian cancer cells in vitro. Transcriptome analysis revealed that CTNNBL1 regulates multiple splicing events and gene expression, including alternative splicing of IFI16 and FOXM1. siRNA knockdown in ovarian cancer cell lines, proliferation and invasion assays, RNA-seq transcriptome analysis of splicing events Experimental cell research Medium 28501461

Source papers

Stage 0 corpus · 100 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1992 Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunology today 433 1510812
2000 The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. The Journal of experimental medicine 239 10790422
1989 Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. The Journal of experimental medicine 222 2681518
1990 Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]). American journal of respiratory cell and molecular biology 218 2189453
1999 Characterization of a novel giant scaffolding protein, CG-NAP, that anchors multiple signaling enzymes to centrosome and the golgi apparatus. The Journal of biological chemistry 216 10358086
2007 Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. The Journal of pharmacology and experimental therapeutics 191 17720885
2002 Centrosomal proteins CG-NAP and kendrin provide microtubule nucleation sites by anchoring gamma-tubulin ring complex. Molecular biology of the cell 191 12221128
1995 Beta-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein. Cell 143 7671305
2005 NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP). CNS drug reviews 127 16614735
2008 Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1. Molecular cell 115 18722174
2014 The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins. Molecular psychiatry 111 25178163
2009 Reduction of nitrate in Shewanella oneidensis depends on atypical NAP and NRF systems with NapB as a preferred electron transport protein from CymA to NapA. The ISME journal 106 19387485
1995 Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity. Blood 102 7812007
1996 NAP-I is a functional homologue of TAF-I that is required for replication and transcription of the adenovirus genome in a chromatin-like structure. Genes to cells : devoted to molecular & cellular mechanisms 94 9077453
2002 Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450. Journal of molecular biology 92 12270714
1992 Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. The Journal of clinical investigation 91 1644918
2007 The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent. FEMS immunology and medical microbiology 84 17521355
2007 The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol. Journal of neurochemistry 84 17623041
2003 Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes and infection 80 12814772
2003 From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division. Journal of molecular neuroscience : MN 80 14501014
1990 Detection of neutrophil-activating peptide NAP/IL-8 and NAP/IL-8 mRNA in human recombinant IL-1 alpha- and human recombinant tumor necrosis factor-alpha-stimulated human dermal fibroblasts. An immunocytochemical and fluorescent in situ hybridization study. Journal of immunology (Baltimore, Md. : 1950) 78 2404062
2000 Association of immature hypophosphorylated protein kinase cepsilon with an anchoring protein CG-NAP. The Journal of biological chemistry 76 10945988
1997 Brassica nap cytoplasmic male sterility is associated with expression of a mtDNA region containing a chimeric gene similar to the pol CMS-associated orf224 gene. Current genetics 76 9108140
2017 ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy. Molecular psychiatry 71 28115743
2014 Deep-sea hydrothermal vent Epsilonproteobacteria encode a conserved and widespread nitrate reduction pathway (Nap). The ISME journal 63 24430487
2007 The neutrophil-activating Dps protein of Helicobacter pylori, HP-NAP, adopts a mechanism different from Escherichia coli Dps to bind and condense DNA. Nucleic acids research 63 17371778
2007 NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell. Current Alzheimer research 63 18220512
2004 The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection. Journal of Alzheimer's disease : JAD 63 15665412
2008 The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 60 18414890
2005 Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures. Journal of molecular neuroscience : MN 60 15800376
1993 cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1). NAP-1 is highly conserved in guinea pig. Journal of immunology (Baltimore, Md. : 1950) 58 7504015
2015 A novel NAP member GhNAP is involved in leaf senescence in Gossypium hirsutum. Journal of experimental botany 57 25991739
2000 NAP-2: histone chaperone function and phosphorylation state through the cell cycle. Journal of molecular biology 56 10764593
2023 A polysaccharide NAP-3 from Naematelia aurantialba: Structural characterization and adjunctive hypoglycemic activity. Carbohydrate polymers 54 37479455
2005 The peptides ADNF-9 and NAP increase survival and neurite outgrowth of rat retinal ganglion cells in vitro. Investigative ophthalmology & visual science 53 15728550
2004 NAP mechanisms of neuroprotection. Journal of molecular neuroscience : MN 53 15314252
2020 When is a transcription factor a NAP? Current opinion in microbiology 52 32120333
2009 The periplasmic nitrate reductase in Shewanella: the resolution, distribution and functional implications of two NAP isoforms, NapEDABC and NapDAGHB. Microbiology (Reading, England) 52 19959582
1997 Identification of NAP-22 and GAP-43 (neuromodulin) as major protein components in a Triton insoluble low density fraction of rat brain. Biochimica et biophysica acta 52 9030206
2008 NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42). BMC neuroscience 51 19091000
2016 NAP-2 Secreted by Human NK Cells Can Stimulate Mesenchymal Stem/Stromal Cell Recruitment. Stem cell reports 49 27052313
2011 NAP (davunetide) provides functional and structural neuroprotection. Current pharmaceutical design 46 21524250
2009 The immune modulating activity of the Helicobacter pylori HP-NAP: Friend or foe? Toxicon : official journal of the International Society on Toxinology 46 19818802
2019 The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse. Translational psychiatry 45 30664622
2017 A pentatricopeptide repeat protein restores nap cytoplasmic male sterility in Brassica napus. Journal of experimental botany 43 28922764
2017 The octapetide NAP alleviates intestinal and extra-intestinal anti-inflammatory sequelae of acute experimental colitis. Peptides 43 29288684
2013 Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP). Neuropeptides 43 24210139
2005 The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury. Current Alzheimer research 43 15974912
2003 The neutrophil-activating protein of Helicobacter pylori (HP-NAP) activates the MAPK pathway in human neutrophils. European journal of immunology 42 12672049
2017 NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression. Journal of cellular physiology 41 28436035
2013 Brain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptides. Pharmaceutical research 40 23549751
2006 NAP, a peptide derived from the activity-dependent neuroprotective protein, modulates macrophage function. Annals of the New York Academy of Sciences 39 16888216
2011 Microtubules (tau) as an emerging therapeutic target: NAP (davunetide). Current pharmaceutical design 35 21902667
2010 Physiological and evolutionary studies of NAP systems in Shewanella piezotolerans WP3. The ISME journal 35 21124486
2021 Enzyme-Specific Coupling of Oxygen and Nitrogen Isotope Fractionation of the Nap and Nar Nitrate Reductases. Environmental science & technology 34 33687201
2011 CTNNBL1 is a novel nuclear localization sequence-binding protein that recognizes RNA-splicing factors CDC5L and Prp31. The Journal of biological chemistry 34 21385873
2007 Role of individual nap gene cluster products in NapC-independent nitrate respiration of Wolinella succinogenes. Microbiology (Reading, England) 34 17975082
2016 Nap Interferes with Hypoxia-Inducible Factors and VEGF Expression in Retina of Diabetic Rats. Journal of molecular neuroscience : MN 33 27909871
2011 A genome-wide survey and functional brain imaging study identify CTNNBL1 as a memory-related gene. Molecular psychiatry 33 22105620
2001 Neutrophil-activating protein (HP-NAP) versus ferritin (Pfr): comparison of synthesis in Helicobacter pylori. FEMS microbiology letters 33 11356582
1997 IL-8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL-8 receptor type A or type B. Cytokine 33 9067094
2020 The ADNP Syndrome and CP201 (NAP) Potential and Hope. Frontiers in neurology 32 33329371
2011 Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects. Current pharmaceutical design 32 21728979
2002 NAP accelerates the performance of normal rats in the water maze. Journal of molecular neuroscience : MN 32 12212775
2014 Davunetide (NAP) protects the retina against early diabetic injury by reducing apoptotic death. Journal of molecular neuroscience : MN 31 24488575
2002 Lipid binding activity of a neuron-specific protein NAP-22 studied in vivo and in vitro. Journal of neuroscience research 31 12271466
2019 NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies. PloS one 30 30865715
2018 Phenazines Regulate Nap-Dependent Denitrification in Pseudomonas aeruginosa Biofilms. Journal of bacteriology 30 29463605
2021 Encapsulation of LXR ligand by D-Nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis. Theranostics 29 33456564
2005 Centrosome-targeting region of CG-NAP causes centrosome amplification by recruiting cyclin E-cdk2 complex. Genes to cells : devoted to molecular & cellular mechanisms 29 15670215
2005 The scaffolding protein CG-NAP/AKAP450 is a critical integrating component of the LFA-1-induced signaling complex in migratory T cells. Journal of immunology (Baltimore, Md. : 1950) 29 16339516
2015 Integrating nap and night-time sleep into sleep patterns reveals differential links to health-relevant outcomes. Journal of sleep research 28 26718988
2003 Sequence, gene structure, and expression pattern of CTNNBL1, a minor-class intron-containing gene--evidence for a role in apoptosis. Genomics 27 12659813
2017 Structural characterization of the NAP; the major adhesion complex of the human pathogen Mycoplasma genitalium. Molecular microbiology 26 28671286
2016 A NAP-Family Histone Chaperone Functions in Abiotic Stress Response and Adaptation. Plant physiology 26 27342307
2016 Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease. Experimental brain research 26 27866262
2011 NAP prevents acute cerebral oxidative stress and protects against long-term brain injury and cognitive impairment in a model of neonatal hypoxia-ischemia. Neurobiology of disease 26 21757007
2009 The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy. Journal of neurochemistry 26 19799711
2021 PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy. Journal of molecular neuroscience : MN 25 33403597
2020 Structure and mechanism of the Nap adhesion complex from the human pathogen Mycoplasma genitalium. Nature communications 25 32513917
2017 Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer. Experimental cell research 25 28501461
2014 NAP reduces murine microvascular endothelial cells proliferation induced by hyperglycemia. Journal of molecular neuroscience : MN 25 24874579
2014 NAP alpha-aminoisobutyric acid (IsoNAP). Journal of molecular neuroscience : MN 24 24458740
1994 Expression and myristoylation of NAP-22 using a baculovirus transfer vector system. Biochimica et biophysica acta 24 8193160
1993 Time- and stimulus-dependent secretion of NAP-1/IL-8 by human fibroblasts and endothelial cells. The Journal of investigative dermatology 24 8409526
2010 Cutting edge: CTNNBL1 is dispensable for Ig class switch recombination. Journal of immunology (Baltimore, Md. : 1950) 23 20585033
2022 HP-NAP of Helicobacter pylori: The Power of the Immunomodulation. Frontiers in immunology 22 35844568
2015 Molecular evolution and species-specific expansion of the NAP members in plants. Journal of integrative plant biology 22 25737328
2013 The Nap family proteins, CG5017/Hanabi and Nap1, are essential for Drosophila spermiogenesis. FEBS letters 22 23454210
2010 Expression of peptide NAP in rat retinal Müller cells prevents hypoxia-induced retinal injuries and promotes retinal neurons growth. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 22 20359852
2005 Shank2E binds NaP(i) cotransporter at the apical membrane of proximal tubule cells. American journal of physiology. Cell physiology 22 15917299
2005 The influence of the peptide NAP on Mac-1-deficient mice following closed head injury. Peptides 21 16042992
2022 Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H . pylori immunostimulatory bacterial transgene. Molecular therapy. Methods & clinical development 20 36092362
2021 Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy. Hepatology communications 20 34558823
2012 D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy. Journal of molecular neuroscience : MN 20 22956189
1997 Structure and bioactivity of recombinant human CTAP-III and NAP-2. Journal of protein chemistry 20 9055206
2010 Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate. Peptides 19 21050875
2022 HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection. Hepatology communications 18 35368148
2018 NAP Protects against Tau Hyperphosphorylation Through GSK3. Current pharmaceutical design 18 30417779
2015 CTNNBL1 facilitates the association of CWC15 with CDC5L and is required to maintain the abundance of the Prp19 spliceosomal complex. Nucleic acids research 18 26130721

Missed literature

Know a paper Affinage missed for CTNNBL1? Flag it for the maintainers and the community.

No submissions yet.